BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22701179)

  • 1. CCN1 Induces β-Catenin Translocation in Esophageal Squamous Cell Carcinoma through Integrin α11.
    Chai J; Modak C; Ouyang Y; Wu SY; Jamal MM
    ISRN Gastroenterol; 2012; 2012():207235. PubMed ID: 22701179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    Deng F; Zhou K; Cui W; Liu D; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCN1 suppresses cell proliferation of esophageal squamous cell carcinoma through amyloid precursor protein without DR6 participation.
    Wang P; Chang Z; Meng J; Cui X; Chai J; Dang T
    Cell Signal; 2022 Aug; 96():110374. PubMed ID: 35654297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLCD1 Suppressed Cellular Proliferation, Invasion, and Migration via Inhibition of Wnt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    He X; Meng F; Yu ZJ; Zhu XJ; Qin LY; Wu XR; Liu ZL; Li Y; Zheng YF
    Dig Dis Sci; 2021 Feb; 66(2):442-451. PubMed ID: 32236884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive correlation of cysteine-rich 61 and target genes of Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    Wang P; Li L; Li T
    J Cancer Res Ther; 2016 Oct; 12(Supplement):19-22. PubMed ID: 27721245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
    Peng H; Zhong XY; Liu KP; Li SM
    Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
    Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
    Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.
    Deng YZ; Chen PP; Wang Y; Yin D; Koeffler HP; Li B; Tong XJ; Xie D
    J Biol Chem; 2007 Dec; 282(50):36571-81. PubMed ID: 17951630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
    Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
    Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLK11 suppresses cellular proliferation via inhibition of Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    He X; Meng F; Qin L; Liu Z; Zhu X; Yu Z; Zheng Y
    Am J Cancer Res; 2019; 9(10):2264-2277. PubMed ID: 31720087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma.
    Zhou H; Wang G; Xiao Z; Yang Y; Tian Z; Gao C; Han X; Sun W; Hou L; Liu J; Xue X
    Front Oncol; 2022; 12():831506. PubMed ID: 35433476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between CK1α and β-catenin Ser45-phosphorylation in patients with esophageal squamous cell carcinoma.
    Pan X; Ma L; Wang J
    Int J Clin Exp Pathol; 2019; 12(10):3928-3933. PubMed ID: 31933784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathological significance and prognostic value of β-catenin Ser45-phosphorylation expression in esophageal squamous cell carcinoma.
    Pan X; Ma L; Wang J
    Int J Clin Exp Pathol; 2019; 12(9):3507-3513. PubMed ID: 31934197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Li J; Chen Y; Zhan C; Zhu J; Weng S; Dong L; Liu T; Shen X
    Dig Dis Sci; 2019 Jun; 64(6):1493-1502. PubMed ID: 30730015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
    Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
    Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
    Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway.
    Wang X; Gao Z; Liao J; Shang M; Li X; Yin L; Pu Y; Liu R
    J Toxicol Environ Health A; 2016; 79(9-10):407-18. PubMed ID: 27267823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
    Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.